RNA Methylation in Cancer Metabolism: from Mechanisms to Therapeutic Opportunities.
One of the most important changes in the transformation of normal cells into tumor cells is metabolism.
APA
Wu Z, Xing Y, et al. (2026). RNA Methylation in Cancer Metabolism: from Mechanisms to Therapeutic Opportunities.. International journal of biological sciences, 22(2), 920-950. https://doi.org/10.7150/ijbs.124177
MLA
Wu Z, et al.. "RNA Methylation in Cancer Metabolism: from Mechanisms to Therapeutic Opportunities.." International journal of biological sciences, vol. 22, no. 2, 2026, pp. 920-950.
PMID
41522342
Abstract
One of the most important changes in the transformation of normal cells into tumor cells is metabolism. In order to satisfy the more active proliferation, migration and metastasis of cancer cells, abnormal changes occur in various pathways and molecules involved in metabolism, which eventually lead to metabolic reprogramming of tumor cells. This process involves the uptake of nutrients and changes in major metabolic forms. As an important part of post-transcriptional epigenetics, RNA methylation modifications can regulate RNA processing and metabolism, while dynamically and reversibly influencing the expression of specific molecules, thereby ultimately affecting diverse biological processes and cellular phenotypes. In this review, various types of RNA methylation modifications involved in cancer are summarized. Subsequently, we systematically elucidate the mechanism of RNA modification for metabolic reprogramming in cancer, including glucose, lipid, amino acid and mitochondrial metabolism. Most importantly, we discuss in depth the clinical significance of RNA modification in metabolic targeted therapy and immunotherapy from mechanism to therapeutic application.
MeSH Terms
Humans; Neoplasms; Methylation; Animals; Epigenesis, Genetic; RNA; RNA Processing, Post-Transcriptional; RNA Methylation
같은 제1저자의 인용 많은 논문 (5)
- Integrated Machine Learning and Multi-Omics Identifies a Novel Molecular Signature for Improving the Prognosis of Hepatocellular Carcinoma.
- Modified Banxia Xiexin Decoction promotes mitochondrial fission in colon cancer cells by inhibiting the CHD6-TMEM65 axis.
- Shared Biomarkers LCN2 and CXCL11 for Ulcerative Colitis and Colon Cancer: Bioinformatics Analysis and Diagnostic Model Construction.
- A novel prognostic signature based on epithelial-mesenchymal transition-associated genes for the prognosis and immune status in breast cancer.
- Delayed-onset functional ischemia 16 years after digital replantation: A Raynaud's-like vasospasm case report.